Cost-Effectiveness of Nivolumab in Combination with Ipilimumab in First-Line Treatment of Advanced Melanoma in Sweden
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.2200
https://www.valueinhealthjournal.com/article/S1098-3015(16)33566-5/fulltext
Title :
Cost-Effectiveness of Nivolumab in Combination with Ipilimumab in First-Line Treatment of Advanced Melanoma in Sweden
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)33566-5&doi=10.1016/j.jval.2016.09.2200
First page :
A730
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2084